Overview
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2025 | The Lustgarten Foundation Honors Revolution Medicines for Transformative Research in Pancreatic Cancer | Linda Tantawi, CEO of the Lustgarten Foundation presents Dr. Mark Goldsmith, Chairman and CEO of Revolution Medicines, with the Hope Through Science award. Revolution Medicines receives inaugural Hope Through Science Award at annual gala, I... |
| Nov 1, 2024 | Break Through Cancer Announces First Patient Enrolled in Phase 2 Trial Targeting Residual Disease in AML | The novel study explores the effects of menin inhibition in acute myeloid leukemia with minimal residual disease as an endpoint. CAMBRIDGE, MA, UNITED STATES, November 1, 2024 /EINPresswire.com/ -- Break Through Cancer, a Boston-based cance... |
| Sep 26, 2024 | No More “Wait and See”: Two Clinical Trials Target the Origins of Recurrent Ovarian Cancer | Break Through Cancer scientists are evaluating a “second-look” technique to measure and destroy persistent cancer cells resistant to frontline chemotherapy. CAMBRIDGE, MA, UNITED STATES, September 26, 2024 /EINPresswire.com/ -- After initia... |
| Apr 4, 2024 | Radical Collaboration: Reimagining Cancer Team Science (6 Hallmarks of Cancer Collaboration) | Break Through Cancer Logo One might assume that there is a widely adopted playbook of best practices for cancer team science. But no such playbook exists—until now. Given the magnitude of the challenge, we need to work together in new ways ... |
| Feb 23, 2023 | More physicians are calling for fallopian tube removal to prevent ovarian cancer | Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women su... |
| Break Through Cancer Launches Collaborative Model Across Top U.S. Research Institutions in Pursuit of Cancer Cures | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 25, 2021-- Break Through Cancer ( www.breakthroughcancer.org ) today announced its formal launch as a public foundation designed to find new solutions to the most intractable challenges in cancer. The ... |
Reviews 0
FAQ about Break Through Cancer
What has the press written about Break Through Cancer?
Parsers VC has collected 7 articles mentioning Break Through Cancer, among them “The Lustgarten Foundation Honors Revolution Medicines for Transformative Research in Pancreatic Cancer” (May 8, 2025) and “Break Through Cancer Announces First Patient Enrolled in Phase 2 Trial Targeting Residual Disease in AML” (Nov 1, 2024).
Is Break Through Cancer still active?
Yes, Break Through Cancer is active; its latest activity on Parsers VC dates from Oct 1, 2025.